KRAS and lung carcinoma: Gene modification through the introduction of various genes is valuable for studying the pathogenesis, metastasis, and drug resistance mechanisms of lung cancer, as well as for evaluating the efficacy of targeted therapies like EGFR and KRAS inhibitors.